Article Details
Retrieved on: 2025-05-01 12:08:58
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... interstitial lung disease (PH-ILD). The company is also developing L606, an investigational sustained-release formulation of treprostinil ...
Article found on: www.manilatimes.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here